| Net loss | -2.29M |
| Depreciation and amortization | 94.69K |
| Stock-based compensation | 0 |
| Recovery of uncollectible royalty receivable | |
| Royalty receivables | |
| Prepaid expenses and other assets | 58.48K |
| Deferred revenue | 20K |
| Accounts payable and accrued expenses | 223.3K |
| Net cash used in operating activities | |
| Purchase of fixed assets | -5.02K |
| Purchase of short term investments | |
| Net cash used in investing activities | |
| Net proceeds from issuance of common stock | |
| Net proceeds from the exercise of options/warrants | |
| Net cash provided by financing activities | |
| Net (decrease) increase in cash and cash equivalents | -1.92M |
| Cash and cash equivalents at beginning of year | 5.71M |
| Cash and cash equivalents at end of period | 3.79M |